Anhui Sunhere Pharmaceutical Excipients Co Ltd Asset Resilience Ratio
Anhui Sunhere Pharmaceutical Excipients Co Ltd asset resilience ratio. Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has an Asset Resilience Ratio of 31.78% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Anhui Sunhere Pharmaceutical Excipients (300452) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Anhui Sunhere Pharmaceutical Excipients Co Ltd (2015–2025)
Asset resilience ratio of Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2015 to 2025. This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's Asset Resilience Ratio has changed over time. Read 300452 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Anhui Sunhere Pharmaceutical Excipients Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Anhui Sunhere Pharmaceutical Excipients .
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥558.43 Million | 31.78% |
| Total Liquid Assets | CN¥558.43 Million | 31.78% |
Asset Resilience Insights
- Very High Liquidity: Anhui Sunhere Pharmaceutical Excipients Co Ltd maintains exceptional liquid asset reserves at 31.78% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Industry Peers by Asset Resilience Ratio
Compare Anhui Sunhere Pharmaceutical Excipients Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Asset Resilience Ratio by Year (2015–2025)
Anhui Sunhere Pharmaceutical Excipients Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Anhui Sunhere Pharmaceutical Excipients Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 30.45% | CN¥521.55 Million ≈ $76.32 Million |
CN¥1.71 Billion ≈ $250.65 Million |
-2.61pp |
| 2024-12-31 | 33.06% | CN¥515.63 Million ≈ $75.45 Million |
CN¥1.56 Billion ≈ $228.24 Million |
-0.11pp |
| 2023-12-31 | 33.17% | CN¥511.77 Million ≈ $74.89 Million |
CN¥1.54 Billion ≈ $225.75 Million |
+15.00pp |
| 2022-12-31 | 18.17% | CN¥214.56 Million ≈ $31.40 Million |
CN¥1.18 Billion ≈ $172.75 Million |
-1.34pp |
| 2021-12-31 | 19.52% | CN¥187.88 Million ≈ $27.49 Million |
CN¥962.58 Million ≈ $140.86 Million |
-1.70pp |
| 2020-12-31 | 21.22% | CN¥191.14 Million ≈ $27.97 Million |
CN¥900.87 Million ≈ $131.83 Million |
+10.67pp |
| 2019-12-31 | 10.54% | CN¥85.41 Million ≈ $12.50 Million |
CN¥810.17 Million ≈ $118.55 Million |
-11.01pp |
| 2018-12-31 | 21.56% | CN¥153.00 Million ≈ $22.39 Million |
CN¥709.75 Million ≈ $103.86 Million |
+0.55pp |
| 2017-12-31 | 21.01% | CN¥140.00 Million ≈ $20.49 Million |
CN¥666.40 Million ≈ $97.52 Million |
-8.24pp |
| 2016-12-31 | 29.25% | CN¥150.00 Million ≈ $21.95 Million |
CN¥512.85 Million ≈ $75.05 Million |
+3.05pp |
| 2015-12-31 | 26.20% | CN¥120.00 Million ≈ $17.56 Million |
CN¥458.06 Million ≈ $67.03 Million |
-- |
About Anhui Sunhere Pharmaceutical Excipients Co Ltd
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.